Loss of Claudin-4 Reduces DNA Damage Repair and Increases Sensitivity to PARP Inhibitors
Tomomi M. Yamamoto(University of Colorado Anschutz Medical Campus), Benjamin G. Bitler(University of Colorado Denver)
Cited by 17
Related Papers
The natural polyamines spermidine and spermine prevent bone loss through preferential disruption of osteoclastic activation in ovariectomized mice
|British Journal of Pharmacology|2012|115
CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer
|Oncogenesis|2018|86
Targeting DUSP Activity as a Treatment for High-Grade Serous Ovarian Carcinoma
|Molecular Cancer Therapeutics|2022|21
Targeting Tryptophan Catabolism in Ovarian Cancer to Attenuate Macrophage Infiltration and PD-L1 Expression
|Cancer Research Communications|2024|21
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation
|Molecular Cancer Therapeutics|2024|11